Atazanavir Sulfate + RitonavirThird Party Manufacturing in India

Atazanavir Sulfate + Ritonavir works by blocking the activity of HIV-1 protease, an essential enzyme that the human immunodeficiency virus needs to replicate and mature.

Atazanavir binds to the active site of HIV-1 protease, preventing the cleavage of viral polyproteins into functional proteins, which ultimately results in the production of immature, non-infectious viral particles. Ritonavir, while also a protease inhibitor, is included in a low dose to act as a pharmacokinetic booster. It works by inhibiting the cytochrome P450 3A4 enzyme in the liver, which is responsible for breaking down atazanavir. By blocking this enzyme, ritonavir significantly increases the concentration of atazanavir in the blood and extends its presence in the body, allowing for a highly effective once-daily dosing regimen.

Unlike single-agent antiretroviral therapies, this boosted combination increases drug exposure and helps prevent the development of drug-resistant viral strains. It is a highly effective, well-tolerated option for adults and pediatric patients managing HIV-1 infection, helping to suppress viral load and support immune function.

Atazanavir Sulfate + Ritonavir third party manufacturing in India is highly sought after due to the global therapeutic success of this boosted protease inhibitor regimen. This pharmaceutical product is a fixed-dose combination containing atazanavir sulfate (CAS number 229975-97-7) and ritonavir (CAS number 155213-67-5), formulated together to simplify clinical dosing.

Therapeutic Uses

Atazanavir Sulfate + Ritonavir is prescribed for the treatment of:

• HIV-1 Infection: Co-administered with other antiretroviral agents for the clinical management of human immunodeficiency virus type 1 in adult and pediatric patients.
• Pharmacokinetic Boosting: Used to enhance the therapeutic efficacy and bioavailability of atazanavir, maintaining consistent therapeutic blood levels.
• Immune System Support: Helps reduce the viral load in the blood, allowing the CD4 T-cell count to recover and strengthening the body's immune defense.
• Prevention of Resistance: Helps suppress viral replication to undetectable levels, reducing the risk of the virus mutating and developing resistance.

Why Choose an Atazanavir Sulfate + Ritonavir Manufacturer in India

Atazanavir Sulfate + Ritonavir is a vital fixed-dose combination widely included in international HIV treatment guidelines. Combining the protease inhibitor and its pharmacokinetic booster into a single daily tablet dramatically improves patient adherence. For pharmaceutical brands, sourcing from a WHO-GMP certified Atazanavir Sulfate + Ritonavir manufacturer ensures compliance with rigorous international regulatory standards. These tablets represent a high-demand product in both domestic government procurement programs and international export markets, particularly across Africa, Latin America, and Southeast Asia. Indian WHO-GMP certified facilities are primary global providers of these essential antiretroviral formulations. The well-established manufacturing process ensures excellent blend uniformity, tablet stability, and cost-effective production at scale.

This makes Atazanavir Sulfate + Ritonavir one of the most sought-after combinations for third party manufacturing in India, with consistent demand from PCD franchise operators, government suppliers, and export-oriented companies.